All news

RDIF, Uniao Quimica plan to invite BRICS to create working group on vaccines

Earlier, the Russian Direct Investment Fund (RDIF) and Brazilian pharmaceutical company Uniao Quimica have agreed to supply 10 mln doses of Sputnik V vaccine to Brazil

MOSCOW, January 13. /TASS/. The Russian Direct Investment Fund (RDIF) and the Brazilian pharmaceutical company Uniao Quimica will invite all BRICS countries to create a working group to combat COVID-19 and cooperate on vaccines, Sputnik V manufacturer reported on Twitter.

"Russia’s RDIF and Brazil’s Uniao Quimica will propose to all BRICS nations to create a task force to fight COVID-19 and to cooperate on vaccines," the statement said.

Earlier, the Russian Direct Investment Fund (RDIF) and Brazilian pharmaceutical company Uniao Quimica have agreed to supply 10 mln doses of Sputnik V vaccine to Brazil. "RDIF to supply 10 mln doses of #SputnikV vaccine to Brazil in the first quarter of 2021. First deliveries will begin as soon as January. Delegation from Brazil’s Uni·o Quimica headed by President Fernando De Castro Marques met today with RDIF CEO Kirill Dmitriev," Sputnik V manufacturer said on Twitter.

Uniao Quimica has started production of the Russian vaccine in Brazil, and started vaccination of the population.

According to RDIF CEO Kirill Dmitriev, the fund and Uniao Quimica will be able to supply 150 mln doses of vaccine to Brazil in 2021.

Russia was the first in the world to register coronavirus vaccine on August 11, 2020, called Sputnik V. The drug was developed by the Gamaleya Research Institute of Epidemiology and Microbiology. Sputnik V is a vector vaccine based on the human adenovirus.